{
  "docId": "019de074-23ea-7254-b381-db7aadcb5c1d",
  "docSlug": "cf70c7f99b18feee93f81e87108bc323",
  "documentTitle": "AbCellera | Investor Conference Presentation Deck | 19 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 19,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-23ea-7254-b381-db7aadcb5c1d/6",
  "deckHref": "/decks/019de074-23ea-7254-b381-db7aadcb5c1d",
  "deckJsonHref": "/decks/019de074-23ea-7254-b381-db7aadcb5c1d.json",
  "deckAnchorHref": "/decks/019de074-23ea-7254-b381-db7aadcb5c1d#slide-6",
  "components": [
    {
      "bbox": {
        "h": 1,
        "w": 0.5,
        "x": 0.5,
        "y": 0
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3e42c063-adc6-4889-9545-ff5a2073a9b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.15,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "STRATEGY #2 Build a large and diversified portfolio of stakes in future antibody therapeutics.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b526061-534f-4586-869a-aa78f380d83e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.5,
        "x": 0.15,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "STRATEGY #1 Be best in world in antibody therapeutics from target to the clinic.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "264c1251-b29b-498a-8c48-f2df1880d6c7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.05,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "title",
      "text": "CORPORATE OVERVIEW",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6e0880d8-b0ab-4ef8-8f07-623cc8885be8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 5,
      "beatId": "2d734aa9-f0e6-4aab-b4f4-134cf1e322c6",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Problem & Complication",
      "beatSlug": "consultants-gambit-problem-complication",
      "evidence": "The document highlights the impact of technology on product creation.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 14,
      "from": 3,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "f61dd81f-4e14-4e3d-a18c-d4800beebb13",
      "evidence": "The document presents a clear pattern of AbCellera's success and potential.",
      "position": 0,
      "objective": "Show the value of AbCellera's technology and portfolio",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    },
    {
      "to": 17,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "96131421-6964-4e15-a1b6-c9e23a66aaed",
      "evidence": "The document implies the cost of inaction in drug development.",
      "position": 1,
      "objective": "Highlight the importance of AbCellera's solution",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}